Erectile Dysfunction, Metabolic Syndrome, Psoriasis
Conditions
Brief summary
complaint of sexual dysfunction and metabolic syndrome are highly reported in men with psoriasis
Detailed description
erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 60) will assigned to study group (group = 30 patients) that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) or control group (group=30 patients) that will receive no lifestyle changes/modifications.
Interventions
BEHAVIORALlifestyle modification (exercise and control of diet)
erectile dysfunction (ED) psoriatic men with metabolic syndrome that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
35 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* psoriatic married men with metabolic syndrome and erectile dysfunction
Exclusion criteria
* patients with heart, respiratory, other autoimmune problems
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| International Index of Erectile Function | It will be measured after 12-week intervention | Arabic version of this 5-item questionnaire will used to assess erectile function/dysfunction |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| psoriasis area and severity index | It will be measured after 12-week intervention | it is a tool used to measure the severity and extent of psoriasis. |
| body mass index | It will be measured after 12-week intervention | patients will be assessed with empty bowel and bladder |
| systolic blood pressure | It will be measured after 12-week intervention | it will be measured using sphygmomanometer |
| diastolic blood presure | It will be measured after 12-week intervention | it will be measured using sphygmomanometer |
| waist circumference | It will be measured after 12-week intervention | it will be measured by in elastic tape |
| blood glucose | It will be measured after 12-week intervention | it will be measured in fasting status |
| triglycerides | It will be measured after 12-week intervention | it will be measured in serum |
| high density lipoprotein | It will be measured after 12-week intervention | it will be measured in serum |
Countries
Egypt
Contacts
Primary ContactAli Ismail, lecturer
Outcome results
None listed